Dora Bianka Balogh (Dora B Balogh)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Angiotensin Converting Enzyme

Cardiovascular Risk Factors

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Dora Bianka Balogh, Laszlo Jozsef Wagner, Andrea Fekete
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis. International journal of molecular sciences 24 (9) (2023)
Dora Bianka Balogh, Laszlo Jozsef Wagner, Andrea Fekete
An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis. International journal of molecular sciences 24 (9) (2023)
Dora Bianka Balogh, Agnes Molnar, Arianna Degi, Akos Toth, Lilla Lenart, Adar Saeed, Adrienn Barczi, Attila J Szabo, Laszlo Jozsef Wagner, George S Reusz, Andrea Fekete
Cardioprotective and Antifibrotic Effects of Low-Dose Renin-Angiotensin-Aldosterone System Inhibitors in Type 1 Diabetic Rat Model. International journal of molecular sciences 24 (23) (2023)
Judit Hodrea, Adar Saeed, Agnes Molnar, Attila Fintha, Adrienn Barczi, Laszlo Jozsef Wagner, Attila J Szabo, Andrea Fekete, Dora Bianka Balogh
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes. PloS one 17 (2) (2022)